“…DHA oxylipins such as 7-, 10-, and 17-hydroxydocosahexaenoic acid (HDoHE), protectin D1 (PD1), resolvin D1 (RvD1), and RvD2 are negatively associated with age-related memory decline and inhibit neuronal cell death through reduction in caspase activation (Bazan, 2005;Hashimoto et al, 2015). Other oxylipins such as eicosapentaenoic acid (EPA)-derived RvE1 have antiinflammatory effects in microglial cells (Rey et al, 2016), and linoleic acid (LNA)-derived 9-hydroxyoctadecadienoic acid (HODE), 13-HODE, and 9,10-dihydroxy-octadecenoic acid are associated with increased brain oxidative stress in the aging brain (Currais et al, 2015). However, while there are reports of selected ARA, EPA, and DHA oxylipins in the brain (Chiabrando et al, 1984;Gerozissis et al, 1983;Koide et al, 1985;Morisseau et al, 2010;Naffah-Mazzacoratti et al, 1995;Schuhmann et al, 2003;Seregi and Hertting, 1984), a comprehensive profile of whole brain oxylipins is needed to identify the oxylipins present and to guide further studies on the potential functions of brain oxylipins.…”